Table 1_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx by Fengwang Xue (22245625)

“…</p>Conclusion<p>Among pneumonia patients receiving glucocorticoid therapy, a decreased PNI was associated with an increased risk of 30-day and 90-day mortality, particularly in those with a PNI < 43.…”

Table 2_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx by Fengwang Xue (22245625)

“…</p>Conclusion<p>Among pneumonia patients receiving glucocorticoid therapy, a decreased PNI was associated with an increased risk of 30-day and 90-day mortality, particularly in those with a PNI < 43.…”

Table 3_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx by Fengwang Xue (22245625)

“…</p>Conclusion<p>Among pneumonia patients receiving glucocorticoid therapy, a decreased PNI was associated with an increased risk of 30-day and 90-day mortality, particularly in those with a PNI < 43.…”

Table 5_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx by Fengwang Xue (22245625)

“…</p>Conclusion<p>Among pneumonia patients receiving glucocorticoid therapy, a decreased PNI was associated with an increased risk of 30-day and 90-day mortality, particularly in those with a PNI < 43.…”

Table 4_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx by Fengwang Xue (22245625)

“…</p>Conclusion<p>Among pneumonia patients receiving glucocorticoid therapy, a decreased PNI was associated with an increased risk of 30-day and 90-day mortality, particularly in those with a PNI < 43.…”

Image 1_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.tif by Fengwang Xue (22245625)

“…</p>Conclusion<p>Among pneumonia patients receiving glucocorticoid therapy, a decreased PNI was associated with an increased risk of 30-day and 90-day mortality, particularly in those with a PNI < 43.…”

Effects of chronic ISO infusion on cardiac function in Epac1TG. by Yoshiki Ohnuki (576298)

Swab cultures around the hole of a needle-removing device. by Miki Doi (15347878)

Impaired development of the brain and iBAT of rarely alive adult <i>aP2-Drp1</i>^f/f mice. by Yuta Ibayashi (20404811)

Co-infected cells express both KSHV and EBV genes <i>in vitro</i> necessary for their survival and growth. by Mitchell Hayes (5334887)

Loss of C1-FDX results in a reduction of the CI and CV activity. by Baoyin Chen (2635399)

The presence of the gRNA targeting <i>OPG147</i> has no effect on transcription of viral entry and early genes. by Xue-Mei Yi (18851202)

The regulation of LGG supplementation of the adaptive immune triggered by <i>M</i>. <i>pneumoniae</i>. by Huanbing Long (19949784)

Supplementation of five Lactobacillus strains affected the colonization of <i>M</i>. <i>pneumoniae</i> and lung injuries. by Huanbing Long (19949784)

Both live and heat-inactivated LGG supplementation attenuated lung tissue injury caused by <i>M</i>. <i>pneumoniae</i> infection. by Huanbing Long (19949784)

Supplementation with LGG effectively influenced the recruitment of innate immune cells following <i>M</i>. <i>pneumoniae</i> infection. by Huanbing Long (19949784)

Data for Figs 8A–8H, 9A–9K, 10A–10I. by Xiaohua Zhang (350570)

“…In <i>vivo</i> experiments further showed that PRV UL4 (¹³²DVAADAAAEAAAAE¹⁴⁵) mutated strain (PRV-UL4^mut) infection did not lead to a significant decrease in viral titers at 12 h. p. i, but it induced lower levels of IL-1β, IL-18, and GSDMD-NT, which led to an alleviated inflammatory infiltration and pathological damage in the lungs and brains, and a lower death rate compared with wild-type PRV strain infection. …”

Mutation of vOPG147 F55, T116 and T117 does not affect replication and production of VACV. by Xue-Mei Yi (18851202)

vOPG147-deficiency promotes innate immune response to VACV. by Xue-Mei Yi (18851202)

OPG147 is associated with MITA. by Xue-Mei Yi (18851202)